AI assistant
Sending…
CLARIVATE PLC — Director's Dealing 2021
Mar 17, 2021
31500_dirs_2021-03-17_a766ae28-7833-46fd-997d-6091b0f9bcec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CLARIVATE Plc (CLVT)
CIK: 0001764046
Period of Report: 2021-03-15
Reporting Person: Ahmed Mukhtar (President, Science Group)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-15 | Ordinary Shares | M | 99102 | $14.78 | Acquired | 149812 | Direct |
| 2021-03-15 | Ordinary Shares | F | 55189 | $26.54 | Disposed | 94623 | Direct |
| 2021-03-15 | Ordinary Shares | S | 43913 | $26.29 | Disposed | 50710 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-15 | Stock Options | $14.78 | M | 99102 | Disposed | 2028-03-08 | Ordinary Shares (99102.0) | Direct |
Footnotes
F1: Represents shares withheld for payment of exercise price.
F2: The price is a weighted average price. The prices actually received ranged from $26.00 to $26.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3: Represents the remaining portion of a March 8, 2018 grant of stock options. The reported stock options became exercisable on November 30, 2020.
More from CLARIVATE PLC
Board/Management Information
2026
Jun 8
Declaration of Voting Results & Voting Rights Announcements
2026
May 18
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17